Baidu
map

Anesth Analg:内源性大麻素在阿立哌唑外周抗伤害作用中的研究

2019-09-30 anesthGH “罂粟花”微信号

研究表明抗精神病药物多巴胺能和5-羟色胺能激动剂阿立哌唑诱导外周抗伤害作用。然而,这一效应的机制尚未完全清楚。本研究旨在确定阿立哌唑的这种作用与内源性大麻素系统之间的关系。

背景与目的

研究表明抗精神病药物多巴胺能和5-羟色胺能激动剂阿立哌唑诱导外周抗伤害作用。然而,这一效应的机制尚未完全清楚。本研究旨在确定阿立哌唑的这种作用与内源性大麻素系统之间的关系。

方  法

所有药物均以20μL的体积局部注射于体重30~35g的雄性瑞士小鼠右后足,足底注射前列腺素E2(2μg)诱发痛觉过敏。在测量前10分钟注射阿立哌唑,并在阿立哌唑前10分钟给予阿立哌唑不可逆抑制剂(MAFP)、单酰甘油脂肪酶抑制剂(JZL184)和大麻素再摄取抑制剂(VDM11)。在注射前列腺素E2后的第三小时使用痛觉测量仪测量痛觉阈值。用方差分析和Bonferroni检验进行数据分析。

结 果

阿立哌唑(100μg)的抗伤害作用可被大麻素1或2受体拮抗剂AM251(40μg[P<.01],80μg[P<.0001]和160μg[P<.0001])和AM630(100μg[P<.0001],200μg[P<.0001]和400μg[P<.0001]))阻断。阿立哌唑(25μg)引起的外周抗伤害作用可被脂肪酸酰胺水解酶抑制剂(MAFP0.5μg[P<.0001])或单酰甘油脂肪酶抑制剂(JZL184,4μg[P<.0001])增强。此外,大麻素再摄取抑制剂(VDM11,2.5μg[P<.0001])也观察到类似的增强作用。

结 论

这些结果为内源性大麻素系统参与阿立哌唑治疗引起的外周抗伤害作用提供了证据。

原始出处:

Renata C. M. Ferreira, MSc, Ana F. Almeida-Santos, et al. Role of Endocannabinoid System in the Peripheral Antinociceptive Action of Aripiprazole. Anesth Analg 2019;129:263–268

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1700108, encodeId=9fc21e001081f, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Oct 26 22:08:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682039, encodeId=6cd616820399e, content=<a href='/topic/show?id=15593040e9a' target=_blank style='color:#2F92EE;'>#内源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30407, encryptionId=15593040e9a, topicName=内源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b46b27929604, createdName=diushouji, createdTime=Fri May 08 22:08:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744759, encodeId=8fc81e447594a, content=<a href='/topic/show?id=d6cc304149c' target=_blank style='color:#2F92EE;'>#内源性大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30414, encryptionId=d6cc304149c, topicName=内源性大麻素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153235436253, createdName=jml2021, createdTime=Mon Oct 28 04:08:00 CST 2019, time=2019-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051447, encodeId=6dad205144e7e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Mar 04 11:08:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633538, encodeId=3b831633538c0, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Fri Jan 10 22:08:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272746, encodeId=d7a012e2746e8, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361187, encodeId=bfa3136118e35, content=<a href='/topic/show?id=5c644406910' target=_blank style='color:#2F92EE;'>#大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44069, encryptionId=5c644406910, topicName=大麻素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97910, encryptionId=f8a09e910a1, topicName=阿立哌唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7662296077, createdName=huhuaidong388, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1700108, encodeId=9fc21e001081f, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Oct 26 22:08:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682039, encodeId=6cd616820399e, content=<a href='/topic/show?id=15593040e9a' target=_blank style='color:#2F92EE;'>#内源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30407, encryptionId=15593040e9a, topicName=内源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b46b27929604, createdName=diushouji, createdTime=Fri May 08 22:08:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744759, encodeId=8fc81e447594a, content=<a href='/topic/show?id=d6cc304149c' target=_blank style='color:#2F92EE;'>#内源性大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30414, encryptionId=d6cc304149c, topicName=内源性大麻素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153235436253, createdName=jml2021, createdTime=Mon Oct 28 04:08:00 CST 2019, time=2019-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051447, encodeId=6dad205144e7e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Mar 04 11:08:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633538, encodeId=3b831633538c0, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Fri Jan 10 22:08:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272746, encodeId=d7a012e2746e8, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361187, encodeId=bfa3136118e35, content=<a href='/topic/show?id=5c644406910' target=_blank style='color:#2F92EE;'>#大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44069, encryptionId=5c644406910, topicName=大麻素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97910, encryptionId=f8a09e910a1, topicName=阿立哌唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7662296077, createdName=huhuaidong388, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1700108, encodeId=9fc21e001081f, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Oct 26 22:08:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682039, encodeId=6cd616820399e, content=<a href='/topic/show?id=15593040e9a' target=_blank style='color:#2F92EE;'>#内源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30407, encryptionId=15593040e9a, topicName=内源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b46b27929604, createdName=diushouji, createdTime=Fri May 08 22:08:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744759, encodeId=8fc81e447594a, content=<a href='/topic/show?id=d6cc304149c' target=_blank style='color:#2F92EE;'>#内源性大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30414, encryptionId=d6cc304149c, topicName=内源性大麻素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153235436253, createdName=jml2021, createdTime=Mon Oct 28 04:08:00 CST 2019, time=2019-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051447, encodeId=6dad205144e7e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Mar 04 11:08:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633538, encodeId=3b831633538c0, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Fri Jan 10 22:08:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272746, encodeId=d7a012e2746e8, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361187, encodeId=bfa3136118e35, content=<a href='/topic/show?id=5c644406910' target=_blank style='color:#2F92EE;'>#大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44069, encryptionId=5c644406910, topicName=大麻素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97910, encryptionId=f8a09e910a1, topicName=阿立哌唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7662296077, createdName=huhuaidong388, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1700108, encodeId=9fc21e001081f, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Oct 26 22:08:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682039, encodeId=6cd616820399e, content=<a href='/topic/show?id=15593040e9a' target=_blank style='color:#2F92EE;'>#内源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30407, encryptionId=15593040e9a, topicName=内源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b46b27929604, createdName=diushouji, createdTime=Fri May 08 22:08:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744759, encodeId=8fc81e447594a, content=<a href='/topic/show?id=d6cc304149c' target=_blank style='color:#2F92EE;'>#内源性大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30414, encryptionId=d6cc304149c, topicName=内源性大麻素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153235436253, createdName=jml2021, createdTime=Mon Oct 28 04:08:00 CST 2019, time=2019-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051447, encodeId=6dad205144e7e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Mar 04 11:08:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633538, encodeId=3b831633538c0, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Fri Jan 10 22:08:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272746, encodeId=d7a012e2746e8, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361187, encodeId=bfa3136118e35, content=<a href='/topic/show?id=5c644406910' target=_blank style='color:#2F92EE;'>#大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44069, encryptionId=5c644406910, topicName=大麻素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97910, encryptionId=f8a09e910a1, topicName=阿立哌唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7662296077, createdName=huhuaidong388, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1700108, encodeId=9fc21e001081f, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Oct 26 22:08:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682039, encodeId=6cd616820399e, content=<a href='/topic/show?id=15593040e9a' target=_blank style='color:#2F92EE;'>#内源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30407, encryptionId=15593040e9a, topicName=内源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b46b27929604, createdName=diushouji, createdTime=Fri May 08 22:08:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744759, encodeId=8fc81e447594a, content=<a href='/topic/show?id=d6cc304149c' target=_blank style='color:#2F92EE;'>#内源性大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30414, encryptionId=d6cc304149c, topicName=内源性大麻素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153235436253, createdName=jml2021, createdTime=Mon Oct 28 04:08:00 CST 2019, time=2019-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051447, encodeId=6dad205144e7e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Mar 04 11:08:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633538, encodeId=3b831633538c0, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Fri Jan 10 22:08:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272746, encodeId=d7a012e2746e8, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361187, encodeId=bfa3136118e35, content=<a href='/topic/show?id=5c644406910' target=_blank style='color:#2F92EE;'>#大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44069, encryptionId=5c644406910, topicName=大麻素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97910, encryptionId=f8a09e910a1, topicName=阿立哌唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7662296077, createdName=huhuaidong388, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
    2020-01-10 AspirantSuo
  6. [GetPortalCommentsPageByObjectIdResponse(id=1700108, encodeId=9fc21e001081f, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Oct 26 22:08:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682039, encodeId=6cd616820399e, content=<a href='/topic/show?id=15593040e9a' target=_blank style='color:#2F92EE;'>#内源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30407, encryptionId=15593040e9a, topicName=内源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b46b27929604, createdName=diushouji, createdTime=Fri May 08 22:08:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744759, encodeId=8fc81e447594a, content=<a href='/topic/show?id=d6cc304149c' target=_blank style='color:#2F92EE;'>#内源性大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30414, encryptionId=d6cc304149c, topicName=内源性大麻素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153235436253, createdName=jml2021, createdTime=Mon Oct 28 04:08:00 CST 2019, time=2019-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051447, encodeId=6dad205144e7e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Mar 04 11:08:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633538, encodeId=3b831633538c0, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Fri Jan 10 22:08:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272746, encodeId=d7a012e2746e8, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361187, encodeId=bfa3136118e35, content=<a href='/topic/show?id=5c644406910' target=_blank style='color:#2F92EE;'>#大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44069, encryptionId=5c644406910, topicName=大麻素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97910, encryptionId=f8a09e910a1, topicName=阿立哌唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7662296077, createdName=huhuaidong388, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
    2019-10-02 kcb069
  7. [GetPortalCommentsPageByObjectIdResponse(id=1700108, encodeId=9fc21e001081f, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Oct 26 22:08:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682039, encodeId=6cd616820399e, content=<a href='/topic/show?id=15593040e9a' target=_blank style='color:#2F92EE;'>#内源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30407, encryptionId=15593040e9a, topicName=内源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b46b27929604, createdName=diushouji, createdTime=Fri May 08 22:08:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744759, encodeId=8fc81e447594a, content=<a href='/topic/show?id=d6cc304149c' target=_blank style='color:#2F92EE;'>#内源性大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30414, encryptionId=d6cc304149c, topicName=内源性大麻素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153235436253, createdName=jml2021, createdTime=Mon Oct 28 04:08:00 CST 2019, time=2019-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051447, encodeId=6dad205144e7e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Mar 04 11:08:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633538, encodeId=3b831633538c0, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Fri Jan 10 22:08:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272746, encodeId=d7a012e2746e8, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361187, encodeId=bfa3136118e35, content=<a href='/topic/show?id=5c644406910' target=_blank style='color:#2F92EE;'>#大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44069, encryptionId=5c644406910, topicName=大麻素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97910, encryptionId=f8a09e910a1, topicName=阿立哌唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7662296077, createdName=huhuaidong388, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1700108, encodeId=9fc21e001081f, content=<a href='/topic/show?id=295524e541' target=_blank style='color:#2F92EE;'>#Anal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2475, encryptionId=295524e541, topicName=Anal)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de3a29999500, createdName=经常头晕, createdTime=Sat Oct 26 22:08:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682039, encodeId=6cd616820399e, content=<a href='/topic/show?id=15593040e9a' target=_blank style='color:#2F92EE;'>#内源性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30407, encryptionId=15593040e9a, topicName=内源性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b46b27929604, createdName=diushouji, createdTime=Fri May 08 22:08:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744759, encodeId=8fc81e447594a, content=<a href='/topic/show?id=d6cc304149c' target=_blank style='color:#2F92EE;'>#内源性大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30414, encryptionId=d6cc304149c, topicName=内源性大麻素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=153235436253, createdName=jml2021, createdTime=Mon Oct 28 04:08:00 CST 2019, time=2019-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051447, encodeId=6dad205144e7e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Mar 04 11:08:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633538, encodeId=3b831633538c0, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Fri Jan 10 22:08:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272746, encodeId=d7a012e2746e8, content=<a href='/topic/show?id=d04f440581e' target=_blank style='color:#2F92EE;'>#大麻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44058, encryptionId=d04f440581e, topicName=大麻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361187, encodeId=bfa3136118e35, content=<a href='/topic/show?id=5c644406910' target=_blank style='color:#2F92EE;'>#大麻素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44069, encryptionId=5c644406910, topicName=大麻素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7387164, createdName=zhangj7108, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401129, encodeId=e94f14011297f, content=<a href='/topic/show?id=f8a09e910a1' target=_blank style='color:#2F92EE;'>#阿立哌唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97910, encryptionId=f8a09e910a1, topicName=阿立哌唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7662296077, createdName=huhuaidong388, createdTime=Wed Oct 02 13:08:00 CST 2019, time=2019-10-02, status=1, ipAttribution=)]

相关资讯

CLIN CHEM:血清和血浆样品中大麻素的检测

合成大麻素是欧洲毒品和毒瘾监测中心对新型精神活性物质进行监测中的最大一个类别。新型类似物的快速增殖使得对这些新衍生物的检测极具挑战性,对开发用于检测这些化合物的所谓“非目标”筛选策略已成为热点研究问题。 本研究中,研究人员开发了新的稳定生物测定法,其中大麻素引起大麻素受体激活致使截短的β-抑制蛋白2(βarr2)募集到大麻素受体,导致分裂萤光素酶的功能互补,进而可以通过生物发光读取。使用己烷

Clinica Chimica Acta:如何验证口腔液中大麻素的液相色谱-串联质谱分析方法

本研究建立了液相色谱串联质谱法用于量化口腔液中的十种大麻素( · 2019-08-06

-->

盘点:大麻也有‘天使’的一面

越来越多的司法管辖区范围内允许大麻,一系列政策措施正在调整它的生产、分配以及授权。人们普遍认为,很少有证据支持大麻作为一种治疗的药剂。然而,几种基于四氢大麻酚(THC)的药物,大麻的活性成分,已被批准作为药物,但关于大麻使用的争论仍然继续。不过,大麻显然已成为治疗学上的一个新领域。这里梅斯医学小编整理了近期关于大麻的重要研究进展与大家一同分享。【1】局部应用大麻有助于治疗皮肤病在美国,大麻在医学上

CLIN CHEM:血清和血浆样品中大麻素的检测新方法

合成大麻素是欧洲毒品和毒瘾监测中心监测的新型精神活性物质中最主要的一组。新型类似物的快速增殖使得对这些新衍生物的检测难度逐渐增大,对开发用于检测这些化合物的所谓“非目标”筛选策略也是近期的热点。 研究人员开发了新的稳定的生物测定法,其中大麻素激活大麻素受体,导致截短的β-抑制蛋白2(βarr2)募集到大麻素受体,与分裂荧光素酶的功能互补,并能够通过生物发光读出。将正常血清(n = 45)和血

NATURE:上海科大解析人源大麻素受体,有助于疼痛管理和治疗肥胖症

人源大麻素受体1(CB1)是Δ9-四氢大麻酚(Δ9-THC)的大脑受体,Δ9-四氢大麻酚是大麻中的主要精神刺激成分。它与两种合成大麻素的复合物的结构在最近终于被解析。这篇发表于本周《自然》的论文Crystal structures of agonist-bound humancannabinoid receptor CB1,揭示了CB1受体的活化机制的新细节,以及Δ9-THC和其他精神刺激类大麻素

CCLM:通过超高效液相色谱串联质谱法评估大麻茶和大麻油标准化制剂中大麻素的浓度和稳定性

近日,国际杂志《Clinical Chemistry and Laboratory Medicine》在线发表了一篇关于通过超高效液相色谱串联质谱法评估大麻茶和大麻油标准化制剂中大麻素的浓度和稳定性的研究。 从古以来,大麻一直被用于缓解神经性疼痛,降低眼内压,增加食欲,以减少恶心和呕吐。精神活性大麻生物碱Δ9-四氢大麻酚(THC)与非精神药物生物碱大麻二酚(CBD)和大麻酚(CBN)的组合显示出

Baidu
map
Baidu
map
Baidu
map